GetTopicDetailResponse(id=fc39259318, topicName=antigen, introduction=antigen, content=null, image=null, comments=1, allHits=468, url=https://h5.medsci.cn/topic?id=2593, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=64396, tagList=[TagDto(tagId=64396, tagName=antigen)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1779985, encodeId=99711e799851e, content=<a href='/topic/show?id=fc39259318' target=_blank style='color:#2F92EE;'>#antigen#</a>, objectTitle=腫瘤個性化治療——腫瘤新抗原Neoantigen療法首次獲批進入臨床試驗, objectType=article, longId=158976, objectId=44f21589e6dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44f21589e6dd, replyNumber=0, likeNumber=71, createdTime=2019-04-03, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44f21589e6dd, moduleTitle=腫瘤個性化治療——腫瘤新抗原Neoantigen療法首次獲批進入臨床試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=44f21589e6dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
